On the stock market since 2024, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
The stock trades below its recent peak — about 8% off the top. A pullback, not a collapse.
Sales run at $261.0M a year. A small number, but proof the product has real buyers.
It pays out $0.97 per share each year — regular cash for whoever holds the stock.
A loss of $11.3M against $261.0M in annual sales.
At the current pace of spending, the cash lasts about 1.1 years. After that, the company needs to find new money.
On our five-subject report card, IRET sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: IRET is a high-risk stock — not yet profitable, and its future rides on its product catching on.